Private Equity 24 Hours

Last updated: June 12, 2026, 11:30 AM ET

European Dealmaking & Fundraising Closed €20bn round for AI startup Mistral and raised €85m for robotics firm Theker illustrate a resurgence of large‑scale financing in Europe despite recent “doomerism” at tech conferences. The Mistral valuation underscores investor appetite for generative‑AI platforms, while Samsung’s backing of Theker signals confidence in industrial automation as manufacturers chase productivity gains. Parallelly, secured €650m first close for real‑estate secondaries positions Partners Group to meet a $1.5bn target, reflecting continued LP interest in liquidity‑driven strategies after a period of caution.

US Private‑Equity Activity Invested in Crowe’s advisory arm marks KKR’s first institutional partnership with a CPA firm, expanding its footprint in high‑margin professional services. In the health‑care space, acquired Compet Medical expands KKA’s portfolio of harm‑reduction products, aligning with a broader trend of PE targeting niche medical‑supply chains. Meanwhile, targeted pediatric speech‑therapy assets—with General Atlantic, Aquitaine Capital, Avesi Partners and PPC Enterprises—highlights private equity’s focus on growing specialty‑care segments driven by early‑intervention diagnostics.

Mega‑Cap Exit & Investor Windfalls Launched SpaceX IPO near $1.8tn valuation generated a historic windfall for early backers such as Founders Fund, Sequoia and Andreessen Horowitz, confirming the market’s readiness to price the world’s most valuable venture‑backed company. The offering, which capped at a valuation of $1.8tn, also sparked commentary on Europe’s lagging public‑market pathways for high‑growth tech firms.

Pension Fund Leadership Shifts Promoted Anton Orlich to oversee private markets after delivering top‑ranked PE returns at Cal PERS, reinforcing the pension giant’s emphasis on alternative‑asset outperformance. Orlich’s expanded mandate now includes private credit, real estate and infrastructure, signaling Cal PERS’ intent to deepen exposure across the alternative spectrum.

Sector‑Specific PE Trends Backed dermatologist‑led Remedy Science as L Catterton’s latest consumer‑specialist bet, tapping the fast‑growing clinically backed beauty market. In industrials, highlighted Thoma Bravo’s interest alongside Astorg‑backed IPCOM’s move to acquire Le Froid Pecomark, underscoring private equity’s attraction to high‑margin, long‑life‑cycle manufacturing assets. Conversely, Warburg Pincus nears JSB acquisition in Japan’s housing sector, reflecting a strategic push into stable, demographic‑driven real‑estate markets.

Legal & Market Framework Developments Supreme Court sided with BlackRock funds delivering a decisive win for asset managers by limiting activist litigation under federal securities law, a ruling that could reshape governance challenges for PE‑backed vehicles. At the same time, continuation vehicles attract renewed LP interest after earlier scepticism, indicating a softening of sentiment toward LP‑led secondaries as investors seek extended hold periods for high‑performing assets.